Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07BNP
|
||||
| Drug Name |
BRL-36378
|
||||
| Synonyms |
BRL-36378; N-[4-(2,3-Dihydrobenzofuran-2-yl)-1-(ethoxycarbonyl)butyl]-L-alanyl-L-proline
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Unspecified | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H32N2O6
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Angiotensin-converting enzyme | Target Info | Modulator | ||
| KEGG Pathway | Renin-angiotensin system | ||||
| Chagas disease (American trypanosomiasis) | |||||
| Hypertrophic cardiomyopathy (HCM) | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | ||||
| WikiPathways | ACE Inhibitor Pathway | ||||
| Metabolism of Angiotensinogen to Angiotensins | |||||
| References | |||||
| REF 1 | Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.